The Functional Assessment Staging Test (FAST) assesses the functioning and daily living abilities of patients with dementia. Healthcare professionals use it to monitor functioning declines, track disease progression and anticipate next steps. It is also a crucial tool for determining hospice eligibility for patients with Alzheimer’s disease (AD).
Alzheimer’s disease is a form of dementia that progresses gradually over time. The FAST scale evaluates declining physical and cognitive abilities in individuals with AD and provides detailed insights into disease progression.
This article explains the FAST scale stages, what to expect during the evaluation process and its implications for hospice care. It also highlights the scale’s limitations and offers guidance for families and caregivers.
What Is the Purpose of the FAST Scale?
The FAST scale is a valuable diagnostic and tracking tool for Alzheimer’s disease, enabling healthcare professionals to assess its progressive stages comprehensively. Dementia, particularly AD, is a progressive condition where symptoms worsen gradually over time. Early stages may involve mild memory changes, while later stages can severely affect daily functioning and communication. Through regular use of the FAST scale, medical professionals can:
- Determine whether a person’s dementia aligns with Alzheimer’s disease.
- Measure the progressive stages of Alzheimer’s over time.
- Identify and address various complications associated with Alzheimer’s.
- Monitor the effectiveness of ongoing treatment plans.
- Guide new treatment approaches based on observed progression.
- Establish eligibility for hospice care for patients in advanced stages.
The FAST scale is specifically designed for Alzheimer’s patients and may not apply to other forms of dementia, such as Lewy Body or vascular dementia. However, it remains a cornerstone for assessing AD progression due to its reliability and precision.
What Are the Stages of the FAST Scale?
The FAST scale outlines seven main stages and multiple sub-stages, tracking the disease’s trajectory from normal functioning to advanced decline. It complements the Global Deterioration Scale (GDS), which also assesses dementia progression. Unlike GDS, the FAST scale provides a more granular breakdown of later stages, offering additional clarity.
Stage 1: No Functional Impairment
No noticeable difficulties, either subjectively or objectively.
Stage 2: Mild Cognitive Decline
Minor forgetfulness, such as misplacing objects or subjective difficulties with work tasks.
Stage 3: Mild Cognitive Impairment
Observable reductions in job performance and organizational skills, noticeable by co-workers. Individuals may struggle with traveling to new locations.
Stage 4: Moderate Cognitive Decline
Increased difficulty with complex tasks, such as managing finances or planning events.
Stage 5: Severe Cognitive Decline
Assistance becomes necessary for daily activities like selecting appropriate clothing for seasons or occasions.
Stage 6: Advanced Functional Decline
It is often the longest phase (lasting 4–8 years), and is divided into five sub-stages:
- Dressing difficulties: Patients may wear shoes on the wrong feet or struggle with buttoning shirts.
- Bathing assistance: Fear of bathing or difficulty adjusting water temperature requires caregiver support.
- Toileting challenges: Forgetting to flush or improper hygiene becomes evident.
- Urinary incontinence: Occurs occasionally or more frequently as the stage progresses.
- Fecal incontinence: Develops alongside or after urinary issues.
Stage 7: End-Stage Decline
Stage 7 is divided into six sub-stages, representing severe physical and cognitive decline:
- Limited speech ability: Speech is reduced to short sentences, with significant difficulty expressing needs.
- Single-word communication: Patients may use a single intelligible word repeatedly.
- Loss of mobility: Ambulation is lost, and walking requires personal assistance.
- Inability to sit independently: Patients can no longer sit upright without support.
- Loss of ability to smile: Emotional recognition and muscle control diminish.
- Head drooping: Patients lose the ability to hold their heads up independently.
While these descriptions outline the stages, caregivers should seek professional evaluations to understand individual patient progression better.
How Accurate Is the FAST Scale?
The FAST scale is one of the most validated tools for assessing Alzheimer’s progression. Its accuracy lies in its consistent ability to track disease stages over time. However, some limitations include:
- Applicability to Alzheimer’s only: The scale is not designed for other dementia types, such as Lewy Body or vascular dementia.
- Sequential staging assumption: The FAST scale assumes a linear progression, but secondary conditions like infections or strokes can cause patients to skip stages.
- Focus on functional abilities: It emphasizes observable changes in functioning, which might not fully capture cognitive shifts.
Despite these challenges, healthcare professionals widely rely on the FAST scale due to its reliability in diagnosing and staging Alzheimer’s.
Can Patients Skip FAST Stages?
For Alzheimer’s dementia, progression through the FAST scale stages is typically linear, with no skipping or regression between steps. However, individuals with non-Alzheimer’s dementias (e.g., Lewy Body or Parkinson’s) may exhibit different patterns of decline, potentially skipping stages due to external factors like medication effects or secondary illnesses.
Regardless of dementia type, patients tend to align with Stage 7a or beyond during the disease’s end stages, reflecting universal declines in physical and cognitive functioning.
What FAST Score Is Needed for Hospice Admission?
The FAST scale is instrumental in determining hospice eligibility for Alzheimer’s patients. Admission criteria typically include reaching Stage 7c or beyond, alongside a prognosis of six months or less. However, eligibility criteria can vary by geographic region, depending on the Medicare Administrative Contractor (MAC) overseeing claims processing in that area.
For patients with additional health conditions or complications, hospice eligibility may be granted even if the FAST threshold has not yet been met. Patients with non-Alzheimer’s dementia require supplemental assessments, such as neuroimaging or evaluations of comorbid conditions, to determine eligibility.
Resources for Caregivers and Families
Understanding the FAST scale can help families and caregivers anticipate the progression of Alzheimer’s and prepare for necessary care interventions. If you have questions about the FAST scale or its implications, consider reaching out to:
- Your healthcare provider.
- Alzheimer’s Association (www.alz.org).
- Local hospice care providers for guidance on admission criteria.
Conclusion
The FAST scale is a trusted tool for diagnosing and staging Alzheimer’s disease, providing critical insights into disease progression and eligibility for hospice care. While it has limitations, its reliability makes it invaluable for medical professionals and caregivers. By understanding the FAST scale stages, families can better support their loved ones through each phase of Alzheimer’s.
If you’d like to learn more about the FAST scale or seek personalized guidance, consult a healthcare professional or explore resources from Alzheimer’s organizations.
Frequently Asked Questions
What does the word “FAST” mean?
The FAST scale is short for Functional Assessment Staging Test. It is a clinical instrument that helps keep track of how Alzheimer’s disease is becoming worse and decide if a patient is eligible for hospice care.
How many levels are there on the FAST scale?
The FAST scale has 7 main stages, and stages 6 and 7 have sub-stages that show how a person goes from having modest cognitive impairment to having significant physical and cognitive deterioration. There are five sub-stages in Stage 6 and six in Stage 7.
At what point on the FAST scale do people usually think about hospice?
People usually think of hospice care when a patient reaches Stage 7c or above. At this stage, they have lost the ability to move and speak and have a life expectancy of six months or less. Other clinical considerations can also affect eligibility.
Is the FAST scale good for all kinds of dementia?
No. The FAST scale is only for Alzheimer’s disease and does not work well for Lewy Body, vascular dementia, or frontotemporal dementia. These other categories generally move forward in distinct ways.
How are the FAST scale and the Global Deterioration Scale (GDS) different?
The FAST scale looks at functional deterioration, especially in the later stages of dementia. The GDS involves a cognitive test and is frequently more general but less detailed in the later stages of Alzheimer’s.
